Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study

PURPOSE: Adjuvant treatment decisions in early breast cancer (eBC) have traditionally been driven by risk stratification based on clinical and pathological risk factors. The 21-gene Oncotype DX® assay has been validated as a predictive test for benefit from adjuvant chemotherapy (CT), hence assessin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zambelli, Alberto, Simoncini, Edda, Giordano, Monica, La Verde, Nicla, Farina, Gabriella, Torri, Valter, Colombo, Giorgio, Piacentini, Giulia, Fotia, Vittoria, Vassalli, Lucia, Pugliese, Palma, Poletti, Paola, Caremoli, Elena Rota, Tondini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375559/
https://www.ncbi.nlm.nih.gov/pubmed/32325372
http://dx.doi.org/10.1016/j.breast.2020.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375559/
https://www.ncbi.nlm.nih.gov/pubmed/32325372
http://dx.doi.org/10.1016/j.breast.2020.04.003

Ejemplares similares